Johnson & Johnson's Mylanta Recalled
Links shared publicly online about this topic
Most Recently Shared on December 22, 2011 at 5:24 pm By:
Quality issue roundup: J & J revamping controls; The odds for orthopedic surgery; Automatic prescription refills and patient compliance
news-medical.net — “The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.” View full resource at news-medical.net
Most Recently Shared on August 20, 2010 at 5:15 am By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic